| scholarly article | Q13442814 |
| P50 | author | Mário Dinis-Ribeiro | Q40943799 |
| Hugo Sousa | Q42797867 | ||
| P2093 | author name string | Luís Moreira-Dias | |
| Carlos Lopes | |||
| Paula Ferreira | |||
| Rui Medeiros | |||
| Carina Pereira | |||
| Maria Fragoso | |||
| P2860 | cites work | Global cancer statistics, 2002 | Q27860562 |
| Increased expression of cyclooxygenase-2 in human pancreatic neoplasms and potential for chemoprevention by cyclooxygenase inhibitors | Q28175922 | ||
| COX-2 and cancer: a new approach to an old problem | Q28191533 | ||
| Aspirin resistance and genetic polymorphisms | Q28195472 | ||
| A functional polymorphism in the promoter region of the cyclooxygenase-2 gene is not associated with asthma and atopy in an Australian population | Q28210185 | ||
| PTGS2 (COX-2) -765G > C promoter variant reduces risk of colorectal adenoma among nonusers of nonsteroidal anti-inflammatory drugs | Q28210376 | ||
| Functional effects and gender association of COX-2 gene polymorphism G-765C in bronchial asthma | Q28211158 | ||
| Biological assessment of aspirin efficacy on healthy individuals: heterogeneous response or aspirin failure? | Q28211882 | ||
| Epidemiology of gastric cancer | Q33788193 | ||
| Role of cyclooxygenases in angiogenesis | Q34060652 | ||
| Cyclooxygenase-2: a target for the prevention and treatment of breast cancer | Q34277077 | ||
| Overexpressing leptin genetic polymorphism (-2548 G/A) is associated with susceptibility to prostate cancer and risk of advanced disease | Q34308505 | ||
| Cyclooxygenase-2: a novel target for cancer chemotherapy? | Q34317347 | ||
| Many actions of cyclooxygenase-2 in cellular dynamics and in cancer | Q34539982 | ||
| Role of an adenovirus E2 promoter binding factor in E1A-mediated coordinate gene control | Q34611866 | ||
| Molecular biomarkers of colorectal carcinogenesis and their role in surveillance and early intervention. | Q35123465 | ||
| Effect of regulated expression of human cyclooxygenase isoforms on eicosanoid and isoeicosanoid production in inflammation | Q35159985 | ||
| Expression of cyclooxygenase-2 in gastric cancer and its relation to liver metastasis and long-term prognosis | Q35435907 | ||
| Increased expression of cyclooxygenase-2 in first-degree relatives of gastric cancer patients | Q35435925 | ||
| A follow up model for patients with atrophic chronic gastritis and intestinal metaplasia | Q35587381 | ||
| Cyclooxygenase 2-derived prostaglandin E2 regulates the angiogenic switch | Q35732971 | ||
| Frequent co-localization of Cox-2 and laminin-5 gamma2 chain at the invasive front of early-stage lung adenocarcinomas | Q35788803 | ||
| Cyclooxygenase as a target in lung cancer | Q35817554 | ||
| Roles of Helicobacter pylori infection and cyclooxygenase-2 expression in gastric carcinogenesis | Q36065580 | ||
| The role of prostaglandins and other eicosanoids in the gastrointestinal tract | Q36123763 | ||
| Correlation between expression of cyclooxygenase-2 and angiogenesis in human gastric adenocarcinoma | Q36178617 | ||
| Interaction between cyclooxygenase-2 gene polymorphism and dietary n-6 polyunsaturated fatty acids on colon cancer risk: the Singapore Chinese Health Study | Q36695052 | ||
| COX-2 gene promoter haplotypes and prostate cancer risk | Q38345290 | ||
| Disruption of Rb/E2F pathway results in increased cyclooxygenase-2 expression and activity in prostate epithelial cells | Q40427776 | ||
| Common promoter variant in cyclooxygenase-2 represses gene expression: evidence of role in acute-phase inflammatory response. | Q40697859 | ||
| Relationship between expression and distribution of cyclooxygenase-2 and bcl-2 in human gastric adenocarcinoma | Q41892618 | ||
| Expression of cyclooxygenase-1 and -2 in urinary bladder carcinomas in vivo and in vitro and prostaglandin E2 synthesis in cultured bladder cancer cells | Q42516846 | ||
| Association between CYP2E1 polymorphisms and susceptibility to prostate cancer | Q43433460 | ||
| A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke | Q44103563 | ||
| The role of vitamin D receptor gene polymorphisms in the susceptibility to prostate cancer of a southern European population | Q44104410 | ||
| Arachidonate lipoxygenase (ALOX) and cyclooxygenase (COX) polymorphisms and colon cancer risk | Q45016568 | ||
| Colorectal adenoma risk is modified by the interplay between polymorphisms in arachidonic acid pathway genes and fish consumption | Q45154644 | ||
| A common polymorphism in the 3'UTR of cyclooxygenase 2/prostaglandin synthase 2 gene and risk of lung cancer in a Chinese population | Q46390548 | ||
| Cancer incidence and mortality in Portugal | Q47401478 | ||
| HER2 polymorphism and breast cancer risk in Portugal | Q49192576 | ||
| Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer. | Q53355583 | ||
| Polymorphism in the nuclear factor kappa-B binding promoter region of cyclooxygenase-2 is associated with an increased risk of bladder cancer. | Q53629616 | ||
| Protective role of the polymorphism CCR2-64I in the progression from squamous intraepithelial lesions to invasive cervical carcinoma. | Q54679695 | ||
| G-308A TNF-α polymorphism is associated with an increased risk of invasive cervical cancer | Q58835532 | ||
| Increased risk of cervical cancer associated with cyclin D1 gene A870G polymorphism | Q58835534 | ||
| Angiotensin I–converting enzyme gene insertion/deletion polymorphism and endometrial human cancer in normotensive and hypertensive women | Q58835538 | ||
| Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. | Q64968005 | ||
| An efficient salt-chloroform extraction of DNA from blood and tissues | Q69445657 | ||
| Over-expression of cyclooxygenase-2 in human prostate adenocarcinoma | Q73223395 | ||
| Genotype Frequencies of Cyclooxygenease 2 (COX2) Rare Polymorphisms for Japanese with and without Colorectal Cancer | Q73326088 | ||
| Cyclooxygenase-2 expression is related to prostaglandin biosynthesis and angiogenesis in human gastric cancer | Q73404061 | ||
| Clinical Implications of Cyclooxygenase Enzymes: COX-1/COX-2 Role of the New NSAIDs | Q74462884 | ||
| Cyclooxygenase-2 expression in endometrial carcinoma: correlation with clinicopathologic parameters and clinical outcome | Q74715926 | ||
| Increased cyclooxygenase-2 expression in duodenal compared with colonic tissues in familial adenomatous polyposis and relationship to the -765G -> C COX-2 polymorphism | Q81805957 | ||
| P433 | issue | 34 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | adenocarcinoma | Q356033 |
| gastric adenocarcinoma | Q18556047 | ||
| P304 | page(s) | 5473-5478 | |
| P577 | publication date | 2006-09-01 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | -765G > C COX-2 polymorphism may be a susceptibility marker for gastric adenocarcinoma in patients with atrophy or intestinal metaplasia | |
| P478 | volume | 12 |
| Q43294461 | -765G>C and 8473T>C polymorphisms of COX-2 and cancer risk: a meta-analysis based on 33 case-control studies |
| Q34521412 | Association between EGF +61A/G polymorphism and gastric cancer in Caucasians |
| Q64242874 | Association between rs20417 polymorphism in cyclooxygenase-2 and gastric cancer susceptibility: Evidence from15 case-control studies |
| Q53992759 | Association of PPARγ gene polymorphisms with osteoarthritis in a southeast Chinese population. |
| Q55158037 | Biochemical pathway analysis of gastric atrophy. |
| Q34984281 | COX-2-765G>C polymorphism increases the risk of cancer: a meta-analysis |
| Q37226327 | Cyclooxygenase 2 polymorphism and colorectal cancer: -765G>C variant modifies risk associated with smoking and body mass index |
| Q57224884 | Cyclooxygenase-2 ( COX -2) gene-765G/C polymorphism and advanced-stage endometriosis in Korean women |
| Q54356789 | Cyclooxygenase-2 -765 G/C polymorphisms and susceptibility to hepatitis B-related liver cancer in Han Chinese population. |
| Q43875819 | Cyclooxygenase-2 polymorphisms and breast cancer associated risk in Pakistani patients |
| Q34333203 | Cyclooxygenase-2 polymorphisms and susceptibility to gastric carcinoma: A meta-analysis |
| Q43961155 | Cyclooxygenase-2 polymorphisms were associated with the risk of gastric cancer: evidence from a meta-analysis based on case-control studies |
| Q36937955 | Dietary fat-gene interactions in cancer |
| Q46826891 | Genetic polymorphisms of cyclooxygenase-2 and colorectal adenoma risk: the Self Defense Forces Health Study |
| Q33596371 | Influence of age and gender on association between -765G > C COX-2 genetic polymorphism and gastric adenocarcinoma risk: a case-control study in Iran |
| Q54401132 | Interaction between COX-2 G-765C and smoking in relation to coronary artery disease in a Chinese Uighur population |
| Q53347846 | Lack of association between cyclooxygenase 2-765G/C gene polymorphism and breast cancer risk in Ahvaz, west-south Iran. |
| Q38902303 | PTGS2 (COX-2) -765 G > C functional promoter polymorphism and its association with risk and lymph node metastasis in nasopharyngeal carcinoma. |
| Q35120350 | PharmGKB summary: very important pharmacogene information for PTGS2. |
| Q37220827 | Polymorphism of -765G > C COX-2 is a risk factor for gastric adenocarcinoma and peptic ulcer disease in addition to H pylori infection: a study from northern India |
| Q58440208 | Polymorphism −765G>C in Cyclooxygenase-2 and Risk of Colorectal Cancer |
| Q37769274 | Potentially functional COX-2-1195G>A polymorphism increases the risk of digestive system cancers: a meta-analysis |
| Q43753509 | Role of cyclooxygenase-2 functional gene polymorphisms in Helicobacter pylori induced gastritis and gastric atrophy |
| Q80799307 | The COX-2 promoter polymorphism -765 G>C is associated with early-onset, conventional and stump gastric cancers |
| Q36113270 | The COX-2-1195AA Genotype Is Associated with Diffuse-Type Gastric Cancer in Korea |
Search more.